Developer docs
API playgroundTry for free, no card

Search company profiles

Stevenage Bioscience Catalyst

Full company profile

uuid0002l4m

Namestring
Stevenage Bioscience Catalyst
Legal namestring
Stevenage Bioscience Catalyst
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Stevenage Bioscience Catalyst (SBC) is a UK-registered not-for-profit open innovation campus founded in 2012, headquartered on Gunnels Wood Road in Stevenage, Hertfordshire within the so-called Golden Triangle connecting London, Cambridge, and Oxford. It operates a multi-building life sciences campus (Incubator, Accelerator, Spark Building, Seed Works, and Lab Hotel) that supplies laboratory and office accommodation, shared scientific infrastructure, and wraparound business and scientific support services to approximately 45 therapeutics companies — making it the largest cluster of cell and gene therapy (CGT) companies in Europe. Major occupiers and partners include GSK, the Cell and Gene Therapy Catapult (which operates a £60m manufacturing centre on site with 12 collaborator units opened in April 2018), LifeArc, and Cytiva (which provides the only Cytiva Technology Lab of its kind in Europe with Biacore, ÄKTA, and Typhoon imaging equipment).

SBC's offering combines physical infrastructure with embedded ecosystem support. Shared scientific facilities include the Cytiva Technology Lab, a free-of-charge Community Lab with autoclaves, PCR, -80°C storage, and BMG ClarioStar plate reader, plus specialist pharma mentorship via the Catalyser Programme — a 3.5-day AI-powered strategy retreat run with Triple Chasm. Business support covers CEO roundtables, funding guidance, investor introductions, pitch workshops, and free One Nucleus membership. The Lab Hotel subsidises early-stage pre-Series A therapeutics start-ups with up to 250 sq ft of rent-free lab and office space for six months, with seven slots per cohort. The site employs 11–50 internal SBC staff (the wider campus supports over 4,000 life sciences jobs), and is funded through rental income, support service fees, and grants from public funders including Wellcome, Innovate UK, BEIS, and the Hertfordshire Local Enterprise Partnership (£1.55m received November 2019).

The business model is a hybrid real-estate-plus-services subscription: companies pay annual rent on incubator/accelerator/spark units (incubator up to 1,000 sq ft), supplemented by fees for business and science support services. Customer acquisition is community-led through alumni referrals, CEO roundtables, accelerator intakes, and partnerships with industry bodies (One Nucleus, Hertfordshire Futures, Triple Chasm). Since 2012, campus companies have collectively raised over £4bn in equity and recorded seven exits. SBC is led by Interim CEO and CFO Andrew Waters following the 2026 passing of founding CEO Dr Sally Ann Forsyth OBE, with Ian Tomlinson as Chairman, Marco Delise as Director of Business and Entrepreneurship, and Liz Hawley as Finance Director.

Short descriptiontext

Stevenage Bioscience Catalyst is a UK not-for-profit open innovation campus, founded in 2012, providing laboratory and office accommodation plus business and scientific support to 45+ therapeutics companies, operating the largest cell and gene therapy cluster in Europe.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStevenage, United Kingdom
HQ citystring
Stevenage
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science incubator, biomedical campus facilities, therapeutics lab space, cell and gene therapy, biotech accelerator programme
Industry1 code
PRIMARYEDAMAHAC
Youth Business Incubators & Accelerators
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Life Science Incubator / Biomedical Campus Facilities
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Laboratory and Office Accommodation
TypeSubscription Recurring
Description

Rental income from laboratory and office space provision to life science companies. SBC provides various space options including Incubator, Accelerator, Spark Building, and Seed Works.

stevenagecatalyst.com
2Business and Science Support Services
TypeProfessional Services
Description

Provides wraparound business and science support including mentorship, funding guidance, access to facilities, and networking events to campus occupiers.

stevenagecatalyst.com
3Accelerator Programme
TypeSubscription Recurring
Description

Free Catalyser accelerator programme for therapeutics start-ups. The Lab Hotel provides rent-free space for 7 early-stage companies for 6 months.

stevenagecatalyst.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Pricing details3 tiers
1Lab Hotel - Rent-free for 6 months
ModelOtherBilling cadenceMulti-year contract
Notes

250 sq ft of space per start-up, access to molecular biology and mammalian tissue culture equipment, 2 office desks, shared facilities including Community Lab and Cytiva Technology Lab. Zero cost facilities and support.

stevenagecatalyst.com
2Incubator Building
ModelSubscriptionBilling cadenceAnnual
Notes

Lab and office units up to 1,000 sq ft. Designed for early stage ventures.

stevenagecatalyst.com
3Accelerator Building
ModelSubscriptionBilling cadenceAnnual
Notes

Larger scale bespoke lab and office accommodation split across three floors.

stevenagecatalyst.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1Lab Hotel
Description

Provides seven organisations with rent-free space for six months in the Incubator building for early-stage start-ups.

stevenagecatalyst.com
+1 more record
Core offering1 text field

Stevenage Bioscience Catalyst is a not-for-profit open innovation biomedical campus that provides laboratory and office accommodation, shared scientific facilities, and business/scientific support services to life sciences companies. The campus offers tiered spaces (Lab Hotel, Incubator, Accelerator, Spark Building, Seed Works) and world-class shared infrastructure including the Cytiva Technology Lab and the £60M Cell and Gene Therapy Catapult Manufacturing Centre.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Companies based at SBC have raised over £4bn in funding since 2012
+5 more records
Product overview1 text field

Stevenage Bioscience Catalyst is an open innovation campus providing laboratory and office accommodation for life science companies engaged in cutting-edge research. The offering consists of physical infrastructure facilities (Incubator Building, Accelerator Building, Spark Building, Seed Works, and Lab Hotel) that provide lab and office spaces ranging from 1,000 sq ft incubator units to larger bespoke accommodation, with the Spark Building specifically supporting cell and gene technology ventures. The campus also provides shared scientific facilities including the Community Lab (free to occupiers), the Cytiva Technology Lab (the only one of its kind in Europe), and the Cell and Gene Therapy Catapult Manufacturing Centre. Business and scientific support services complement the physical infrastructure, including the Catalyser Programme accelerator for therapeutics start-ups. Companies based on campus employ over 4,000 people and have raised over 4 billion pounds in funding.

Product and service11 records
1Lab Hotel
CategoryIncubator Programme
Description

Rent-free laboratory and office accommodation programme that houses up to 7 early-stage biotech start-ups for 6 months in the Incubator building. Each start-up receives approximately 250 sq ft of space, access to molecular biology and mammalian tissue culture equipment, two office desks, and shared access to the Community Lab and Cytiva Technology Lab. Selection criteria include developing therapeutics, wet-lab activity, and pre-Series A funding status.

2Incubator Building
3Accelerator Building
4Spark Building
5Seed Works
6Catalyser Programme
7Community Lab
8Cytiva Technology Lab
9Cell and Gene Therapy Catapult Manufacturing Centre
CategoryShared Manufacturing Facility
Description

World-leading manufacturing centre with 12 collaborator units, serving SMEs through to multinationals with equipment, specialists and supply chain to fast-track cell and gene therapies to patients.

10Business Support Services
11Scientific Support Services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major organisation based on campus sharing facilities including shuttle bus, restaurant, and gym. Provides access to scientific journals for occupiers. Located adjacent to SBC on Stevenage Campus.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

£60 million manufacturing centre opened in 2018 with 12 collaborator units. Provides development, scale-up and commercialisation support for cell and gene therapies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major organisation based on campus contributing to the therapeutics ecosystem.

Strategic tierCoreTypeTechnology or Integration
Description

Provides state-of-the-art Technology Lab equipment including VIA Freeze Uno, Biacore 8K+, Biacore T200, Amersham Typhoon 5, ÄKTA avant, and ÄKTA pure. Only Cytiva Technology Lab of its kind in Europe.

5Triple Chasm
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partners with SBC for the Catalyser accelerator programme. Provides AI-powered strategy retreat for therapeutics start-ups.

stevenagecatalyst.com
Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partners with SBC for the Catalyser programme and broader ecosystem development in Hertfordshire.

Strategic tierSupportingTypeGTM or Marketing Partner
Description

Free membership to One Nucleus provided to Lab Hotel occupiers for networking and industry access.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partnered with Genenet Technology for product development support.

Strategic tierSupportingTypeStrategic or Co-development Partner
Description

Partnered with Genenet Technology for product development support.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Babraham Research Campus
TypeDirect peer
Description

Cambridge-area biotech and life sciences incubator campus operating a similar model of lab/office accommodation plus accelerator programs (e.g. Babraham Accelerator). Directly comparable to SBC as a UK biotech R&D campus with shared facilities and start-up support services.

TypeDirect peer
Description

UK-based life sciences and tech incubator providing lab and office space, accelerator programs (e.g. BioCity Accelerator) and business support to early-stage therapeutics and diagnostics companies. Closest direct competitor in the UK incubator market to SBC's Lab Hotel / Incubator / Accelerator model.

3Cambridge Science Park
TypeDirect peer
Description

Long-established UK science park in Cambridge offering lab and office accommodation to life sciences and tech companies. Direct UK peer to SBC for laboratory-let space within the Golden Triangle.

TypeDirect peer
Description

Large former-ICI life sciences campus in Cheshire offering lab space, accelerator (Alderley Park Accelerator) and shared equipment to biotech start-ups and scale-ups. Directly comparable UK biotech incubator with similar Lab Hotel-style facilities.

5Manchester Science Park
TypeDirect peer
Description

UK science park providing office and lab space plus business support to life sciences and tech start-ups, with specific biotech/health programs. Comparable UK regional incubator competitor to SBC.

TypeDirect peer
Description

Edinburgh-based life sciences campus co-locating academic, clinical and commercial tenants, including lab space for biotech companies. Comparable UK biology and life sciences incubator model to SBC.

TypeDirect peer
Description

Oxford-based science park offering lab and office accommodation to life sciences start-ups and scale-ups within the Golden Triangle. Direct UK peer competing for the same therapeutics tenant base as SBC.

TypeRegional player
Description

Royal Holloway-linked London biotech incubator providing lab and office space plus business support to early-stage life sciences companies. UK peer with overlapping lab-incubation model but central London rather than Stevenage location.

9Chesterford Research Park
TypeDirect peer
Description

Cambridge-region park offering bespoke lab and office space to life sciences SMEs and scale-ups within the Golden Triangle. Comparable high-quality UK biotech property peer to SBC.

TypeBroad incumbent
Description

UK Catapult centre with a £60m manufacturing centre physically located on the SBC campus. While not a direct competitor, it is the dominant UK advanced-therapy manufacturing platform and a key SBC partner/infrastructural anchor; relevant as a broader-incumbent CGT platform operator.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers12 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Stevenage Bioscience Catalyst

Life Science Incubator / Biomedical Campus Facilitiesstevenagecatalyst.com

Stevenage Bioscience Catalyst is a UK not-for-profit open innovation campus, founded in 2012, providing laboratory and office accommodation plus business and scientific support to 45+ therapeutics companies, operating the largest cell and gene therapy cluster in Europe.

What Stevenage Bioscience Catalyst does

Stevenage Bioscience Catalyst (SBC) is a UK-registered not-for-profit open innovation campus founded in 2012, headquartered on Gunnels Wood Road in Stevenage, Hertfordshire within the so-called Golden Triangle connecting London, Cambridge, and Oxford. It operates a multi-building life sciences campus (Incubator, Accelerator, Spark Building, Seed Works, and Lab Hotel) that supplies laboratory and office accommodation, shared scientific infrastructure, and wraparound business and scientific support services to approximately 45 therapeutics companies — making it the largest cluster of cell and gene therapy (CGT) companies in Europe. Major occupiers and partners include GSK, the Cell and Gene Therapy Catapult (which operates a £60m manufacturing centre on site with 12 collaborator units opened in April 2018), LifeArc, and Cytiva (which provides the only Cytiva Technology Lab of its kind in Europe with Biacore, ÄKTA, and Typhoon imaging equipment).

SBC's offering combines physical infrastructure with embedded ecosystem support. Shared scientific facilities include the Cytiva Technology Lab, a free-of-charge Community Lab with autoclaves, PCR, -80°C storage, and BMG ClarioStar plate reader, plus specialist pharma mentorship via the Catalyser Programme — a 3.5-day AI-powered strategy retreat run with Triple Chasm. Business support covers CEO roundtables, funding guidance, investor introductions, pitch workshops, and free One Nucleus membership. The Lab Hotel subsidises early-stage pre-Series A therapeutics start-ups with up to 250 sq ft of rent-free lab and office space for six months, with seven slots per cohort. The site employs 11–50 internal SBC staff (the wider campus supports over 4,000 life sciences jobs), and is funded through rental income, support service fees, and grants from public funders including Wellcome, Innovate UK, BEIS, and the Hertfordshire Local Enterprise Partnership (£1.55m received November 2019).

The business model is a hybrid real-estate-plus-services subscription: companies pay annual rent on incubator/accelerator/spark units (incubator up to 1,000 sq ft), supplemented by fees for business and science support services. Customer acquisition is community-led through alumni referrals, CEO roundtables, accelerator intakes, and partnerships with industry bodies (One Nucleus, Hertfordshire Futures, Triple Chasm). Since 2012, campus companies have collectively raised over £4bn in equity and recorded seven exits. SBC is led by Interim CEO and CFO Andrew Waters following the 2026 passing of founding CEO Dr Sally Ann Forsyth OBE, with Ian Tomlinson as Chairman, Marco Delise as Director of Business and Entrepreneurship, and Liz Hawley as Finance Director.

Stevenage Bioscience Catalyst firmographics

Firmographics
Name
Stevenage Bioscience Catalyst
Legal name
Stevenage Bioscience Catalyst
Website
https://stevenagecatalyst.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Stevenage Bioscience Catalyst is a UK not-for-profit open innovation campus, founded in 2012, providing laboratory and office accommodation plus business and scientific support to 45+ therapeutics companies, operating the largest cell and gene therapy cluster in Europe.
Ownership category
akta.pro rank

Stevenage Bioscience Catalyst industry classification

Industry
Product category
Life Science Incubator / Biomedical Campus Facilities
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYEDAMAHAC
Youth Business Incubators & Accelerators

Keywords

  • Life science incubator
  • Biomedical campus facilities
  • Therapeutics lab space
  • Cell and gene therapy
  • Biotech accelerator programme

Where Stevenage Bioscience Catalyst is headquartered

Location

Headquarters

HQ city
Stevenage
HQ country
United Kingdom
HQ region
Europe

Offices5 records

Markets served

Stevenage Bioscience Catalyst business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Laboratory and Office Accommodation: Rental income from laboratory and office space provision to life science companies. SBC provides various space options including Incubator, Accelerator, Spark Building, and Seed Works.
  2. Business and Science Support Services: Provides wraparound business and science support including mentorship, funding guidance, access to facilities, and networking events to campus occupiers.
  3. Accelerator Programme: Free Catalyser accelerator programme for therapeutics start-ups. The Lab Hotel provides rent-free space for 7 early-stage companies for 6 months.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractLab Hotel - Rent-free for 6 months
SubscriptionAnnualIncubator Building
SubscriptionAnnualAccelerator Building

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Stevenage Bioscience Catalyst product offering

Product offering

Core offering

Stevenage Bioscience Catalyst is a not-for-profit open innovation biomedical campus that provides laboratory and office accommodation, shared scientific facilities, and business/scientific support services to life sciences companies. The campus offers tiered spaces (Lab Hotel, Incubator, Accelerator, Spark Building, Seed Works) and world-class shared infrastructure including the Cytiva Technology Lab and the £60M Cell and Gene Therapy Catapult Manufacturing Centre.

Product overview

Stevenage Bioscience Catalyst is an open innovation campus providing laboratory and office accommodation for life science companies engaged in cutting-edge research. The offering consists of physical infrastructure facilities (Incubator Building, Accelerator Building, Spark Building, Seed Works, and Lab Hotel) that provide lab and office spaces ranging from 1,000 sq ft incubator units to larger bespoke accommodation, with the Spark Building specifically supporting cell and gene technology ventures. The campus also provides shared scientific facilities including the Community Lab (free to occupiers), the Cytiva Technology Lab (the only one of its kind in Europe), and the Cell and Gene Therapy Catapult Manufacturing Centre. Business and scientific support services complement the physical infrastructure, including the Catalyser Programme accelerator for therapeutics start-ups. Companies based on campus employ over 4,000 people and have raised over 4 billion pounds in funding.

Differentiator

Problem solved

Functional benefit

Brands

  • Lab Hotel: Provides seven organisations with rent-free space for six months in the Incubator building for early-stage start-ups.
  • Catalyser Programme

Products and services

  • Lab Hotel Rent-free laboratory and office accommodation programme that houses up to 7 early-stage biotech start-ups for 6 months in the Incubator building. Each start-up receives approximately 250 sq ft of space, access to molecular biology and mammalian tissue culture equipment, two office desks, and shared access to the Community Lab and Cytiva Technology Lab. Selection criteria include developing therapeutics, wet-lab activity, and pre-Series A funding status.
  • Incubator Building
  • Accelerator Building
  • Spark Building
  • Seed Works
  • Catalyser Programme
  • Community Lab
  • Cytiva Technology Lab
  • Cell and Gene Therapy Catapult Manufacturing Centre World-leading manufacturing centre with 12 collaborator units, serving SMEs through to multinationals with equipment, specialists and supply chain to fast-track cell and gene therapies to patients.
  • Business Support Services
  • Scientific Support Services

Quantifiable outcome

  • Companies based at SBC have raised over £4bn in funding since 2012
  • +5 more outcomes

Companies that use Stevenage Bioscience Catalyst

Customer profile

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Stevenage Bioscience Catalyst technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Stevenage Bioscience Catalyst partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and supporting.

  • GSKcoreStrategic or Co-development PartnerMajor organisation based on campus sharing facilities including shuttle bus, restaurant, and gym. Provides access to scientific journals for occupiers. Located adjacent to SBC on Stevenage Campus.
  • Cell and Gene Therapy Catapult (CGTC)coreStrategic or Co-development Partner£60 million manufacturing centre opened in 2018 with 12 collaborator units. Provides development, scale-up and commercialisation support for cell and gene therapies.
  • LifeArccoreStrategic or Co-development PartnerMajor organisation based on campus contributing to the therapeutics ecosystem.
  • CytivacoreTechnology or IntegrationProvides state-of-the-art Technology Lab equipment including VIA Freeze Uno, Biacore 8K+, Biacore T200, Amersham Typhoon 5, ÄKTA avant, and ÄKTA pure. Only Cytiva Technology Lab of its kind in Europe.
  • Triple ChasmcoreStrategic or Co-development PartnerPartners with SBC for the Catalyser accelerator programme. Provides AI-powered strategy retreat for therapeutics start-ups.
  • Hertfordshire FuturessupportingStrategic or Co-development PartnerPartners with SBC for the Catalyser programme and broader ecosystem development in Hertfordshire.
  • One NucleussupportingGTM or Marketing PartnerFree membership to One Nucleus provided to Lab Hotel occupiers for networking and industry access.
  • Centre for Process Innovation (CPI)supportingStrategic or Co-development PartnerPartnered with Genenet Technology for product development support.
  • Medicine Discovery CatapultsupportingStrategic or Co-development PartnerPartnered with Genenet Technology for product development support.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Stevenage Bioscience Catalyst competitors and assessment

Company assessment

Direct peers

  • Babraham Research Campus: Cambridge-area biotech and life sciences incubator campus operating a similar model of lab/office accommodation plus accelerator programs (e.g. Babraham Accelerator). Directly comparable to SBC as a UK biotech R&D campus with shared facilities and start-up support services.
  • BioCity: UK-based life sciences and tech incubator providing lab and office space, accelerator programs (e.g. BioCity Accelerator) and business support to early-stage therapeutics and diagnostics companies. Closest direct competitor in the UK incubator market to SBC's Lab Hotel / Incubator / Accelerator model.
  • Cambridge Science Park: Long-established UK science park in Cambridge offering lab and office accommodation to life sciences and tech companies. Direct UK peer to SBC for laboratory-let space within the Golden Triangle.
  • Alderley Park: Large former-ICI life sciences campus in Cheshire offering lab space, accelerator (Alderley Park Accelerator) and shared equipment to biotech start-ups and scale-ups. Directly comparable UK biotech incubator with similar Lab Hotel-style facilities.
  • Manchester Science Park: UK science park providing office and lab space plus business support to life sciences and tech start-ups, with specific biotech/health programs. Comparable UK regional incubator competitor to SBC.
  • Edinburgh BioQuarter: Edinburgh-based life sciences campus co-locating academic, clinical and commercial tenants, including lab space for biotech companies. Comparable UK biology and life sciences incubator model to SBC.
  • The Oxford Science Park: Oxford-based science park offering lab and office accommodation to life sciences start-ups and scale-ups within the Golden Triangle. Direct UK peer competing for the same therapeutics tenant base as SBC.
  • Chesterford Research Park: Cambridge-region park offering bespoke lab and office space to life sciences SMEs and scale-ups within the Golden Triangle. Comparable high-quality UK biotech property peer to SBC.

Regional players

  • London BioScience Innovation Centre (LBIC): Royal Holloway-linked London biotech incubator providing lab and office space plus business support to early-stage life sciences companies. UK peer with overlapping lab-incubation model but central London rather than Stevenage location.

Broad incumbents

  • Cell and Gene Therapy Catapult: UK Catapult centre with a £60m manufacturing centre physically located on the SBC campus. While not a direct competitor, it is the dominant UK advanced-therapy manufacturing platform and a key SBC partner/infrastructural anchor; relevant as a broader-incumbent CGT platform operator.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Stevenage Bioscience Catalyst social profiles

Digital presence

Stevenage Bioscience Catalyst compliance and trust

Trust signal

Compliance1 record

Stevenage Bioscience Catalyst financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Stevenage Bioscience Catalyst leadership team

Management profile

Number of profiles

Profiles4 records

Stevenage Bioscience Catalyst funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Stevenage Bioscience Catalyst M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Stevenage Bioscience Catalyst

What does Stevenage Bioscience Catalyst do?

Stevenage Bioscience Catalyst is a not-for-profit open innovation biomedical campus that provides laboratory and office accommodation, shared scientific facilities, and business/scientific support services to life sciences companies. The campus offers tiered spaces (Lab Hotel, Incubator, Accelerator, Spark Building, Seed Works) and world-class shared infrastructure including the Cytiva Technology Lab and the £60M Cell and Gene Therapy Catapult Manufacturing Centre.

Is Stevenage Bioscience Catalyst a public or private company?

Stevenage Bioscience Catalyst is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Stevenage Bioscience Catalyst founded?

Stevenage Bioscience Catalyst was founded in 2012. It employs 11 to 50 people.

Where is Stevenage Bioscience Catalyst based?

Stevenage Bioscience Catalyst is headquartered in Stevenage, United Kingdom, in the Europe region.

How does Stevenage Bioscience Catalyst make money?

Three revenue lines are on record. Laboratory and Office Accommodation is the primary driver. The others are business and Science Support Services and accelerator Programme.

Who are Stevenage Bioscience Catalyst's main competitors?

Direct peers on record are Babraham Research Campus, BioCity, Cambridge Science Park, Alderley Park, Manchester Science Park, Edinburgh BioQuarter, The Oxford Science Park and Chesterford Research Park. London BioScience Innovation Centre (LBIC) is listed as a regional player. Cell and Gene Therapy Catapult is listed as a broad incumbent.

Does Stevenage Bioscience Catalyst have an API?

No public API is recorded for Stevenage Bioscience Catalyst.

What industry is Stevenage Bioscience Catalyst in?

Stevenage Bioscience Catalyst's product category is Life Science Incubator / Biomedical Campus Facilities. Its primary akta.pro industry code is EDAMAHAC, Youth Business Incubators & Accelerators. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
UKSPAStatement from Stevenage Bioscience Catalyst on GSK’s continued investment in UK life sciencesGSK announced continued investment in UK life sciences, prompting a statement from Stevenage Bioscience Catalyst. The campus, home to over 45 companies, has raised more than £4 billion in investment since 2012. SBC will continue supporting its collaborative community and partnerships across the Golden Triangle.UKSPALab Hotel at Stevenage Bioscience Catalyst now fully bookedStevenage Bioscience Catalyst awarded space in its Lab Hotel to Neobe Therapeutics and Genenet Technology, bringing the facility to capacity with four start-ups. The free lab and office accommodation supports early-stage therapeutics companies for six months, with access to scientific and business support.UKSPAStevenage Bioscience Catalyst – Developer named for campus expansionGSK will gift land to Stevenage Bioscience Catalyst to enable campus expansion, with UBS Asset Management and Reef Group developing a new site. The project includes up to £900m investment and 1.4 million square feet, creating up to 5,000 jobs, with construction starting in 2023 and some elements opening by 2025.Business Wire BlogReport Demonstrates Stevenage Bioscience Catalyst’s Key Role in Delivering the Economic Benefit From Leading Edge UK Life SciencesStevenage Bioscience Catalyst (SBC) released an independent report detailing its significant economic contribution to the UK life sciences sector, highlighting a current gross value added of £87m per annum and the attraction of £2.3bn in finance by occupier companies. The report outlines projections for future growth, including a potential 4,500 new jobs and cumulative net GVA of £740m over the next 20 years, driven by the cluster's strength in cell and gene therapy. GlaxoSmithKline, a founding partner located on the same campus, plans to further expand the site into one of Europe’s largest life science campuses.